Pharmacokinetics of intravenous and intramuscular tramadol in llamas.

The purpose of this study was to determine the pharmacokinetics of tramadol and its metabolite M1 after intravenous and intramuscular administration to llamas. Tramadol, a centrally acting analgesic whose efficacy is a result of complex interactions between opiate, adrenergic and serotonin receptor systems, has been used clinically to treat moderate to severe pain in humans. The pharmacokinetic parameters of tramadol and M1 in plasma were examined following intravenous and intramuscular administration to six healthy male llamas. Tramadol half-life, volume of distribution at steady-state and clearance after intravenous administration were 2.12 ± 0.37 h, 4.02 ± 1.16 L/kg and 1728.73 ± 152.82 mL/h/kg, respectively. The bioavailability was 110 ± 21% and half-life 2.54 ± 0.31 h following intramuscular administration of tramadol. M1 had a half-life of 10.40 ± 2.90 h and 7.71 ± 0.54 h following intravenous and intramuscular administration of tramadol.

[1]  P. Cagnardi,et al.  Pharmacokinetics and efficacy of intravenous and extradural tramadol in dogs. , 2010, Veterinary journal.

[2]  T. Tobin,et al.  Intravenous tramadol: effects, nociceptive properties, and pharmacokinetics in horses. , 2009, Veterinary anaesthesia and analgesia.

[3]  M. Giorgi,et al.  Pharmacokinetics of Tramadol and Its Metabolites M1, M2, and M5 in Donkeys after Intravenous and Oral Immediate Release Single-Dose Administration , 2009 .

[4]  C. Padovani,et al.  Analgesic efficacy of perioperative use of vedaprofen, tramadol or their combination in cats undergoing ovariohysterectomy⋆ , 2009, Journal of feline medicine and surgery.

[5]  M. Elghazali,et al.  The pharmacokinetics, metabolism and urinary detection time of tramadol in camels. , 2008, Veterinary journal.

[6]  M. Britzi,et al.  Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration. , 2007, Journal of veterinary pharmacology and therapeutics.

[7]  J. Flório,et al.  Pharmacokinetics of tramadol and o-desmethyltramadol in goats after intravenous and oral administration. , 2007, Journal of veterinary pharmacology and therapeutics.

[8]  B. Pypendop,et al.  Pharmacokinetics of tramadol, and its metabolite O-desmethyl-tramadol, in cats. , 2007, Journal of veterinary pharmacology and therapeutics.

[9]  M. Giorgi,et al.  Pharmacokinetics of Tramadol and its Metabolites M1, M2 and M5 in Horses Following Intravenous, Immediate Release (Fasted/Fed) and Sustained Release Single Dose Administration , 2007 .

[10]  K. Brøsen,et al.  Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers , 2006, European Journal of Clinical Pharmacology.

[11]  B. Kukanich,et al.  Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs. , 2004, Journal of veterinary pharmacology and therapeutics.

[12]  B. Streel,et al.  Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol. , 2003, British journal of clinical pharmacology.

[13]  D. Fantoni,et al.  A comparison of preoperative tramadol and morphine for the control of early postoperative pain in canine ovariohysterectomy. , 2003, Veterinary anaesthesia and analgesia.

[14]  I. Trocóniz,et al.  Pharmacokinetic/Pharmacodynamic Modeling of the Antinociceptive Effects of (+)-Tramadol in the Rat: Role of Cytochrome P450 2D Activity , 2003, Journal of Pharmacology and Experimental Therapeutics.

[15]  A. Mutlib,et al.  Metabolism of (S)-5,6-difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone, a non-nucleoside reverse transcriptase inhibitor, in human liver microsomes. Metabolic activation and enzyme kinetics. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[16]  G. Kearns,et al.  Concordance between Tramadol and Dextromethorphan Parent/Metabolite Ratios: The Influence of CYP2D6 and Non‐CYP2D6 Pathways on Biotransformation , 2002, Journal of clinical pharmacology.

[17]  D. G. Walters,et al.  Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[18]  R. Raffa,et al.  Metabolism of the analgesic drug, tramadol hydrochloride, in rat and dog , 2001, Xenobiotica; the fate of foreign compounds in biological systems.

[19]  C. Natalini,et al.  Evaluation of the analgesic effects of epidurally administered morphine, alfentanil, butorphanol, tramadol, and U50488H in horses. , 2000, American journal of veterinary research.

[20]  I. Trocóniz,et al.  Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats. , 2000, The Journal of pharmacology and experimental therapeutics.

[21]  C. Gillen,et al.  Affinity, potency and efficacy of tramadol and its metabolites at the cloned human µ-opioid receptor , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  C. Perry,et al.  Tramadol , 2000, Drugs.

[23]  T. Meuser,et al.  Serum concentrations of tramadol enantiomers during patient-controlled analgesia. , 1999, British journal of clinical pharmacology.

[24]  H. Dengler,et al.  PHARMACOKINETICS AND DISPOSITION , 1997 .

[25]  L. Arendt-Nielsen,et al.  The hypoalgesic effect of tramadol in relation to CYP2D6 * , 1996, Clinical pharmacology and therapeutics.

[26]  D. Smith,et al.  Species differences in metabolism and pharmacokinetics: are we close to an understanding? , 1991, Drug metabolism reviews.

[27]  K. Lehmann,et al.  Postoperative Patient‐Controlled Analgesia with Tramadol: Analgesic Efficacy and Minimum Effective Concentrations , 1990 .

[28]  A. Kaneps,et al.  Anesthesia in the llama. , 1989, Veterinary surgery : VS.

[29]  W. Engelhardt,et al.  Water metabolism in the llama. , 1975, Comparative biochemistry and physiology. A, Comparative physiology.